In the context of COVID-19, SARS-CoV-2 has been shown to directly stimulate NET release from healthy neutrophils, a process that is dependent on angiotensin-converting enzyme 2 (ACE2) and active viral replication (63). The gene discussed is ACE2; the disease is COVID-19.